Citation Impact
Citing Papers
Distinctive patterns of microRNA expression in primary muscular disorders
2007
A Sulfilimine Bond Identified in Collagen IV
2009 StandoutScienceNobel
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
2015
CD21/35 Promotes Protective Immunity to Streptococcus pneumoniae through a Complement-Independent but CD19-Dependent Pathway That Regulates PD-1 Expression
2009
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
2021
Molecular targeting therapy for pancreatic cancer
2004
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice
2007
The genome of a lepidopteran model insect, the silkworm Bombyx mori
2008 Standout
Identification of conserved microRNAs in Bombyx mori (silkworm) and regulation of fibroin L chain production by microRNAs in heterologous system
2008
Adenovirus infection induces amplification of persistent viral DNA sequences (simian virus 40, hepatitis B virus, bovine papillomavirus) in human and rodent cells
1990 StandoutNobel
Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169
1990 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
The DSIF Subunits Spt4 and Spt5 Have Distinct Roles at Various Phases of Immunoglobulin Class Switch Recombination
2012 StandoutNobel
MicroRNA In Situ Hybridization
2011
Prodrug Strategies in Anticancer Chemotherapy
2007
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
2001
Substrate-Specific Kinetics of Dicer-Catalyzed RNA Processing
2010 StandoutNobel
Anti-glomerular basement membrane disease
2003
Dynamic regulation of miRNA expression in ordered stages of cellular development
2007
Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB
2007
Biomedical applications of biodegradable polymers
2011 Standout
miRBase: tools for microRNA genomics
2007 Standout
Potent antibody drug conjugates for cancer therapy
2009
miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades
2011 Standout
Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens
2017
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
2011 Standout
Delivery of rapamycin to dendritic cells using degradable microparticles
2008
Herpes simplex virus type 1 mutants for the origin-binding protein induce DNA amplification in the absence of viral replication
1990 StandoutNobel
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody
2004
Systemic Lupus Erythematosus
2011 Standout
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
2008 StandoutNobel
Role of inflammation in the aging bones
2014
The Remarkable Flexibility of the Human Antibody Repertoire; Isolation of Over One Thousand Different Antibodies to a Single Protein, BLyS
2003
PI3K/Akt signalling pathway and cancer
2003 Standout
Substrate-specific structural rearrangements of human Dicer
2013 StandoutNobel
Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood
2010
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen
2003
Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, “minor” D segments or D-D recombination 1 1Edited By J. Karn
1997 StandoutNobel
Emerging formats for next-generation antibody drug conjugates
2015
Oncogenic DNA viruses
2001 StandoutNobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
2007 Standout
Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis
2006
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
MicroRNA
2017 Standout
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Mechanistic Constraints on Diversity in Human V(D)J Recombination
1996
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
V(D)J-mediated Translocations in Lymphoid Neoplasms: A Functional Assessment of Genomic Instability by Cryptic Sites
2002
RNA sequence analysis defines Dicer's role in mouse embryonic stem cells
2007
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome
1989 StandoutNobel
MicroRNAs in Cancer
2009 Standout
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products.
1989
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
2014
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
2010 Standout
Herpes simplex-1 DNA polymerase
1989
Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program
2014
Marine natural products
2018 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
The regulation of genes and genomes by small RNAs
2007 StandoutNobel
Immunogenicity and Efficacy ofCryptococcus neoformansCapsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human Immunoglobulin Transgenic Mice
2003
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Viruses In Human Tumors–Reminiscences And Perspectives
1996 StandoutNobel
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
1990 StandoutNobel
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury
2009
Structural and functional homology between mammalian DNase IV and the 5'-nuclease domain of Escherichia coli DNA polymerase I.
1994 StandoutNobel
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
2008
Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play”
2016
Works of Michael Gallo being referenced
A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes
2008
The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans
2000
Single variable domains from the T cell receptor β chain function as mono- and bifunctional CARs and TCRs
2019
A single-molecule method for the quantitation of microRNA gene expression
2005
Human antiglomerular basement membrane autoantibody disease in XenoMouse II11See Editorial by Borza and Hudson, p. 1905.
2002
Transgenic Mice as a Source of Fully Human Antibodies for the Treatment of Cancer
1999
The mechanism of V(D)J recombination: site-specificity, reaction fidelity and immunologic diversity
1994
The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase
1989
Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin Loci
2000
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
2006
Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase
1988